If I'd bought $5,000 of NIB shares 5 years ago, here's how much I'd have now!

Atop the capital gains, NIB shares have also delivered two annual dividends over the past five years.

| More on:
Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

NIB Holdings Ltd (ASX: NHF) shares aren't joining in the broader market rally today.

The S&P/ASX 200 Index (ASX: XJO) is up 1% in early afternoon trade on Friday, while shares in the ASX 200 private health insurer are down 0.5% to $7.43 apiece.

That sees the stock down 16% since hitting fresh all-time closing highs of $8.85 on 21 June this year.

Still, you're unlikely to hear longer-term investors complaining about their returns.

If I'd bought $5,000 of NIB shares five years ago, here's how much I'd have today.

NIB shares outperform the ASX 200 over the long-run

Over the past five years the ASX 200 has gained a very respectable 36.3%.

But the health insurer's stock has outpaced those gains.

Five years ago, I could have bought NIB shares for $4.98 apiece. Meaning my $5,000 would have seen me snap up 1,004 shares, with a bit of pocket change left over.

Today those shares are swapping hands for $7.43, up 49.2%.

If I were to sell my stock today then, I'd get $7,459.72. Or a very tidy $2,459.72 in profit on my $5,000 investment. (Excluding potential brokerage fees.)

But wait. There's more.

Don't forget the dividends!

Atop the capital gains, NIB shares have also delivered two fully franked dividends for every one of the past five years. The health insurer's stock currently trades on a trailing dividend yield of 3.8%.

As for the past five years, the company has paid out a total of $1.11 in dividends.

Assuming I spent that dividend income as it came in, rather than reinvesting, then we can add that to the current share price.

This then works out to an accumulated value of $8.54 per NIB share, with some potential tax benefits from those franking credits.

That would make my 1,004 shares worth $8,574.16 today, all from my original $5,000 investment five years ago.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »